Hugo_Symbol	source_struct	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	x1000Genome_AA	x1000Genome_AC	x1000Genome_AF	x1000Genome_AFR_AF	x1000Genome_AMR_AF	x1000Genome_AN	x1000Genome_ASN_AF	x1000Genome_AVGPOST	x1000Genome_CIEND	x1000Genome_CIPOS	x1000Genome_END	x1000Genome_ERATE	x1000Genome_EUR_AF	x1000Genome_HOMLEN	x1000Genome_HOMSEQ	x1000Genome_LDAF	x1000Genome_RSQ	x1000Genome_SNPSOURCE	x1000Genome_SVLEN	x1000Genome_SVTYPE	x1000Genome_THETA	x1000Genome_VT	ACHILLES_Lineage_Results_Top_Genes	CGC_CancerGermlineMut	CGC_CancerMolecularGenetics	CGC_CancerSomaticMut	CGC_CancerSyndrome	CGC_Chr	CGC_ChrBand	CGC_GeneID	CGC_Name	CGC_OtherGermlineMut	CGC_TissueType	COSMIC_n_overlapping_mutations	COSMIC_overlapping_mutation_descriptions	COSMIC_overlapping_primary_sites	ClinVar_ASSEMBLY	ClinVar_HGMD_ID	ClinVar_SYM	ClinVar_TYPE	ClinVar_rs	ECNT	ESP_AA	ESP_AAC	ESP_AA_AC	ESP_AA_AGE	ESP_AA_GTC	ESP_AvgAAsampleReadDepth	ESP_AvgEAsampleReadDepth	ESP_AvgSampleReadDepth	ESP_CA	ESP_CDP	ESP_CG	ESP_CP	ESP_Chromosome	ESP_DBSNP	ESP_DP	ESP_EA_AC	ESP_EA_AGE	ESP_EA_GTC	ESP_EXOME_CHIP	ESP_FG	ESP_GL	ESP_GM	ESP_GS	ESP_GTC	ESP_GTS	ESP_GWAS_PUBMED	ESP_MAF	ESP_PH	ESP_PP	ESP_Position	ESP_TAC	ESP_TotalAAsamplesCovered	ESP_TotalEAsamplesCovered	ESP_TotalSamplesCovered	Ensembl_so_accession	Ensembl_so_term	Familial_Cancer_Genes_Reference	Familial_Cancer_Genes_Synonym	HCNT	HGNC_EnsemblGeneID	HGNC_HGNCID	HGNC_RefSeqIDs	HGNC_Status	HGNC_UCSCIDsuppliedbyUCSC	HGVS_coding_DNA_change	HGVS_genomic_change	HGVS_protein_change	MAX_ED	MIN_ED	NLOD	ORegAnno_bin	PON	QSS	TLOD	UniProt_alt_uniprot_accessions	allelic_depth	alt_allele_in_normal	alt_allele_seen	annotation_transcript	build	ccds_id	center	clustered_events	dbNSFP_1000Gp1_AC	dbNSFP_1000Gp1_AF	dbNSFP_1000Gp1_AFR_AC	dbNSFP_1000Gp1_AFR_AF	dbNSFP_1000Gp1_AMR_AC	dbNSFP_1000Gp1_AMR_AF	dbNSFP_1000Gp1_ASN_AC	dbNSFP_1000Gp1_ASN_AF	dbNSFP_1000Gp1_EUR_AC	dbNSFP_1000Gp1_EUR_AF	dbNSFP_Ancestral_allele	dbNSFP_CADD_phred	dbNSFP_CADD_raw	dbNSFP_CADD_raw_rankscore	dbNSFP_ESP6500_AA_AF	dbNSFP_ESP6500_EA_AF	dbNSFP_Ensembl_geneid	dbNSFP_Ensembl_transcriptid	dbNSFP_FATHMM_pred	dbNSFP_FATHMM_rankscore	dbNSFP_FATHMM_score	dbNSFP_GERP_NR	dbNSFP_GERP_RS	dbNSFP_GERP_RS_rankscore	dbNSFP_Interpro_domain	dbNSFP_LRT_Omega	dbNSFP_LRT_converted_rankscore	dbNSFP_LRT_pred	dbNSFP_LRT_score	dbNSFP_LR_pred	dbNSFP_LR_rankscore	dbNSFP_LR_score	dbNSFP_MutationAssessor_pred	dbNSFP_MutationAssessor_rankscore	dbNSFP_MutationAssessor_score	dbNSFP_MutationTaster_converted_rankscore	dbNSFP_MutationTaster_pred	dbNSFP_MutationTaster_score	dbNSFP_Polyphen2_HDIV_pred	dbNSFP_Polyphen2_HDIV_rankscore	dbNSFP_Polyphen2_HDIV_score	dbNSFP_Polyphen2_HVAR_pred	dbNSFP_Polyphen2_HVAR_rankscore	dbNSFP_Polyphen2_HVAR_score	dbNSFP_RadialSVM_pred	dbNSFP_RadialSVM_rankscore	dbNSFP_RadialSVM_score	dbNSFP_Reliability_index	dbNSFP_SIFT_converted_rankscore	dbNSFP_SIFT_pred	dbNSFP_SIFT_score	dbNSFP_SLR_test_statistic	dbNSFP_SiPhy_29way_logOdds	dbNSFP_SiPhy_29way_logOdds_rankscore	dbNSFP_SiPhy_29way_pi	dbNSFP_UniSNP_ids	dbNSFP_Uniprot_aapos	dbNSFP_Uniprot_acc	dbNSFP_Uniprot_id	dbNSFP_aaalt	dbNSFP_aapos	dbNSFP_aapos_FATHMM	dbNSFP_aapos_SIFT	dbNSFP_aaref	dbNSFP_cds_strand	dbNSFP_codonpos	dbNSFP_folddegenerate	dbNSFP_genename	dbNSFP_hg18_pos1coor	dbNSFP_phastCons100way_vertebrate	dbNSFP_phastCons100way_vertebrate_rankscore	dbNSFP_phastCons46way_placental	dbNSFP_phastCons46way_placental_rankscore	dbNSFP_phastCons46way_primate	dbNSFP_phastCons46way_primate_rankscore	dbNSFP_phyloP100way_vertebrate	dbNSFP_phyloP100way_vertebrate_rankscore	dbNSFP_phyloP46way_placental	dbNSFP_phyloP46way_placental_rankscore	dbNSFP_phyloP46way_primate	dbNSFP_phyloP46way_primate_rankscore	dbNSFP_refcodon	dbSNP_membership	gencode_transcript_name	gencode_transcript_status	gencode_transcript_tags	gencode_transcript_type	gene_id	gene_type	genotype	genotype_quality	germline_risk	havana_transcript	homologous_mapping_event	id	individual_barcode	multi_event_alt_allele_in_normal	panel_of_normals	phred_scaled_likelihoods	platform	qual	read_depth	sample_allelic_fraction	sample_name	secondary_variant_classification	strand	t_lod_fstar	tumor_subtype	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	ClippingRankSum	downsampled_samples	maximum_likelihood_expectation_allelic_count	maximum_likelihood_expectation_allelic_frequency	validation_judgement_wgs	validation_power_wgs	validation_tumor_alt_count_wgs	validation_tumor_ref_count_wgs	validation_normal_alt_count_wgs	validation_normal_ref_count_wgs	discovery_tumor_alt_count_wgs	discovery_tumor_ref_count_wgs	discovery_normal_alt_count_wgs	discovery_normal_ref_count_wgs	site	type	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_HGVS_coding_DNA_change	i_HGVS_genomic_change	i_HGVS_protein_change	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	i_init_n_lod	i_n_alt_count	i_n_ref_count
OR8I2	1	120586	broad.mit.edu	37	11	55861485	55861485	+	Silent	SNP	G	G	A			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	3813c301-9622-4567-bc72-d17acbeb236f	dde29d2e-09a2-4467-a8f4-2b1d37ce634a	g.chr11:55861485G>A	ENST00000302124.2	+	1	733	c.702G>A	c.(700-702)caG>caA	p.Q234Q	OR8I2_ENST00000560768.1_3'UTR			Q8N0Y5	OR8I2_HUMAN	olfactory receptor, family 8, subfamily I, member 2	234		NA		NA	sensory perception of smell	integral to membrane|plasma membrane	olfactory receptor activity			NS(1)|breast(2)|endometrium(16)|haematopoietic_and_lymphoid_tissue(2)|large_intestine(4)|lung(24)|ovary(1)|skin(2)|upper_aerodigestive_tract(1)	53	Esophageal squamous(21;0.00693)					CAGGCAGGCAGAAGGCCTTCT	0.468		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA	1						152	138	143	NA		NA	NA	11		NA											NA				55861485		2201	4296	6497	SO:0001819	synonymous_variant			2	ENSG00000172154	HGNC:15310	NM_001003750	Approved	uc010rix.2	ENST00000302124.2:c.702G>A	chr11.hg19:g.55861485G>A		NA	NA	36.67	NA	NA	3591	33.33	B2RNN4|Q6IFC0|Q96RC5	110,15	PASS	True	ENST00000302124.2	hg19	CCDS31517.1	broad.mit.edu	PASS																																																																																			False	OR8I2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	0/1	NA	PASS	OTTHUMT00000391539.1	PASS		LUAD-TCGA-64-1681	PASS	PASS	NA	illumina	None	NA	0.121	TCGA-64-1681-01A-11D-2063-08		+	PASS	NA	1	0.9996837	14	92	0	86	15	111	0	128	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	11:55861485:A:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	M2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ATM	1	472	broad.mit.edu	37	11	108139190	108139190	+	Missense_Mutation	SNP	T	T	G			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	3813c301-9622-4567-bc72-d17acbeb236f	dde29d2e-09a2-4467-a8f4-2b1d37ce634a	g.chr11:108139190T>G	ENST00000452508.2	+	19	2881	c.2692T>G	c.(2692-2694)Tta>Gta	p.L898V	ATM_ENST00000278616.4_Missense_Mutation_p.L898V			Q13315	ATM_HUMAN	ataxia telangiectasia mutated	898		NA		NA	cell cycle arrest|cellular response to gamma radiation|DNA damage induced protein phosphorylation|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|double-strand break repair via homologous recombination|G2/M transition DNA damage checkpoint|histone mRNA catabolic process|mitotic cell cycle spindle assembly checkpoint|negative regulation of B cell proliferation|peptidyl-serine phosphorylation|positive regulation of DNA damage response, signal transduction by p53 class mediator|pre-B cell allelic exclusion|protein autophosphorylation|reciprocal meiotic recombination|replicative senescence	cytoplasmic membrane-bounded vesicle|nucleoplasm	1-phosphatidylinositol-3-kinase activity|ATP binding|DNA binding|DNA-dependent protein kinase activity|identical protein binding|protein complex binding|protein dimerization activity|protein N-terminus binding			NS(4)|breast(23)|central_nervous_system(11)|endometrium(10)|haematopoietic_and_lymphoid_tissue(227)|kidney(19)|large_intestine(53)|liver(5)|lung(62)|ovary(6)|pancreas(4)|prostate(13)|skin(4)|stomach(1)|upper_aerodigestive_tract(3)|urinary_tract(3)	448		all_cancers(61;9.64e-12)|all_epithelial(67;9.97e-08)|Melanoma(852;2.55e-06)|Acute lymphoblastic leukemia(157;3.95e-05)|all_hematologic(158;0.00014)|Breast(348;0.0258)|all_neural(303;0.072)		Epithelial(105;9.05e-06)|BRCA - Breast invasive adenocarcinoma(274;1.06e-05)|all cancers(92;0.000208)|Colorectal(284;0.116)|OV - Ovarian serous cystadenocarcinoma(223;0.147)		TCTACTTTTCTTAGACATGCT	0.373		NA	"""D, Mis, N, F, S"""		T-PLL	"""leukemia, lymphoma, medulloblastoma, glioma"""	NA	Genes defective in diseases associated with sensitivity to DNA damaging agents	Ataxia Telangiectasia	TSP Lung(14;0.12)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Rec	yes	Ataxia-telangiectasia	11	11q22.3	472	ataxia telangiectasia mutated	NA	"""L, O"""	0							NA	1						215	213	213	NA		NA	NA	11		NA											NA				108139190		2201	4298	6499	SO:0001583	missense	Familial Cancer Database	AT, Louis-Bar syndrome	1	ENSG00000149311	HGNC:795	NM_000051	Approved	uc001pkb.1	ENST00000452508.2:c.2692T>G	chr11.hg19:g.108139190T>G	unknown_prot_seq_id:p.Leu898Val	NA	NA	58.59	NA	NA	4634	46.13	B2RNX5|O15429|Q12758|Q16551|Q93007|Q9NP02|Q9UCX7	138,20	PASS	True	ENST00000452508.2	hg19	CCDS31669.1	broad.mit.edu	PASS	.	.	.	.	.	.	.	.	.	.	T	16.88	3.244705	0.59103	.	.	ENSG00000149311	ENST00000527805;ENST00000278616;ENST00000452508	T;T;T	0.80824	-1.42;-1.42;-1.42	5.96	3.63	0.41609	Armadillo-type fold (1);	0.000000	0.64402	D	0.000001	T	0.79811	0.4510	M	0.72894	2.215	0.35721	D	0.817167	D	0.59357	0.985	P	0.49665	0.618	T	0.81230	-0.1027	10	0.41790	T	0.15	.	4.599	0.12343	0.0:0.4259:0.0:0.5741	.	898	Q13315	ATM_HUMAN	V	898	ENSP00000435747:L898V;ENSP00000278616:L898V;ENSP00000388058:L898V	ENSP00000278616:L898V	L	+	1	2	ATM	107644400	0.999000	0.42202	0.824000	0.32777	0.809000	0.45718	3.245000	0.51407	1.075000	0.40932	0.533000	0.62120	TTA	False	ATM-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	0/1	NA	PASS	OTTHUMT00000389938.1	PASS		LUAD-TCGA-64-1681	PASS	PASS	NA	illumina	None	NA	0.136	TCGA-64-1681-01A-11D-2063-08		+	PASS	NA	1	1	37	260	0	501	20	138	0	231	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	11:108139190:G:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	M2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SIN3A	1	25942	broad.mit.edu	37	15	75714964	75714964	+	Nonsense_Mutation	SNP	C	C	T			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	3813c301-9622-4567-bc72-d17acbeb236f	dde29d2e-09a2-4467-a8f4-2b1d37ce634a	g.chr15:75714964C>T	ENST00000567289.1	-	3	664	c.390G>A	c.(388-390)tgG>tgA	p.W130*	SIN3A_ENST00000360439.4_Intron|SIN3A_ENST00000394947.3_Intron|SIN3A_ENST00000394949.4_Intron			Q96ST3	SIN3A_HUMAN	SIN3 transcription regulator family member A	517	Interaction with HCFC1.|PAH 1.	NA		NA	blood coagulation|cellular lipid metabolic process|negative regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleolus|Sin3 complex	protein binding			breast(2)|central_nervous_system(1)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(16)|lung(15)|ovary(3)|prostate(2)|skin(5)|upper_aerodigestive_tract(2)	63						ATTTTTTGACCCAAGAAAAAG	0.458		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA	1						59	62	61	NA		NA	NA	15		NA											NA				75714964		2197	4294	6491	SO:0001587	stop_gained			2	ENSG00000169375	HGNC:19353	NM_015477	Approved	uc002bai.3	ENST00000567289.1:c.390G>A	chr15.hg19:g.75714964C>T	unknown_prot_seq_id:p.Trp130*	NA	NA	24.93	NA	NA	1818	19.99	B2RNS5|Q8N8N4|Q8NC83|Q8WV18|Q96L98|Q9UFQ1	55,8	PASS	True	ENST00000567289.1	hg19		broad.mit.edu	PASS																																																																																			False	SIN3A-003	KNOWN	basic	protein_coding	NA	protein_coding	0/1	NA	PASS	OTTHUMT00000420314.1	PASS		LUAD-TCGA-64-1681	PASS	PASS	NA	illumina	None	NA	0.133	TCGA-64-1681-01A-11D-2063-08		-	PASS	NA	1	0.9426475	8	31	0	58	8	57	0	91	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	15:75714964:T:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	M2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TP53	1	7157	broad.mit.edu	37	17	7578392	7578392	+	Missense_Mutation	SNP	C	C	T			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	3813c301-9622-4567-bc72-d17acbeb236f	dde29d2e-09a2-4467-a8f4-2b1d37ce634a	g.chr17:7578392C>T	ENST00000420246.2	-	5	670	c.538G>A	c.(538-540)Gag>Aag	p.E180K	TP53_ENST00000269305.4_Missense_Mutation_p.E180K|TP53_ENST00000455263.2_Missense_Mutation_p.E180K|TP53_ENST00000445888.2_Missense_Mutation_p.E180K|TP53_ENST00000413465.2_Missense_Mutation_p.E180K|TP53_ENST00000574684.1_5'UTR|TP53_ENST00000359597.4_Missense_Mutation_p.E180K	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	180	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42.	NA	E -> A (in a sporadic cancer; somatic mutation).|E -> D (in sporadic cancers; somatic mutation).|E -> G (in a sporadic cancer; somatic mutation).|E -> K (in LFS; germline mutation and in sporadic cancers; somatic mutation).|E -> Q (in sporadic cancers; somatic mutation).|E -> V (in a sporadic cancer; somatic mutation).	NA	activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.E180*(14)|p.P177_C182delPHHERC(8)|p.0?(8)|p.E180K(5)|p.C176_R181delCPHHER(3)|p.R174fs*24(3)|p.H178_S183delHHERCS(3)|p.R175_E180delRCPHHE(3)|p.P177fs*3(2)|p.V173fs*59(2)|p.C176fs*65(1)|p.V173fs*23(1)|p.V172_E180delVVRRCPHHE(1)|p.E180Q(1)|p.R81fs*24(1)|p.E180>DGRCPHQ(1)|p.R174_E180>K(1)|p.H46_S51delHHERCS(1)|p.H178fs*6(1)|p.P177_E180delPHHE(1)|p.R42fs*24(1)|p.H85_S90delHHERCS(1)|p.R174fs*3(1)|p.E180fs*6(1)|p.E171fs*61(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GAGCAGCGCTCATGGTGGGGG	0.637		111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""	NA	Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53	NA	"""L, E, M, O"""	66	Deletion - In frame(21)|Substitution - Nonsense(14)|Deletion - Frameshift(14)|Whole gene deletion(8)|Substitution - Missense(6)|Insertion - Frameshift(1)|Complex - insertion inframe(1)|Complex - deletion inframe(1)	large_intestine(16)|upper_aerodigestive_tract(9)|urinary_tract(6)|breast(6)|lung(5)|oesophagus(4)|bone(4)|central_nervous_system(3)|haematopoietic_and_lymphoid_tissue(3)|ovary(3)|stomach(2)|liver(2)|pancreas(2)|prostate(1)	GRCh37	CM941328	TP53	M	NA	1						47	47	47	NA		NA	NA	17		NA											NA				7578392		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	1	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	ENST00000420246.2:c.538G>A	chr17.hg19:g.7578392C>T	unknown_prot_seq_id:p.Glu180Lys	NA	NA	12.94	NA	NA	792	61.98	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	23,23	PASS	True	ENST00000420246.2	hg19	CCDS45606.1	broad.mit.edu	PASS	.	.	.	.	.	.	.	.	.	.	C	26.1	4.704841	0.88924	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000509690;ENST00000514944;ENST00000414315	D;D;D;D;D;D;D;D	0.99784	-6.74;-6.74;-6.74;-6.74;-6.74;-6.74;-6.74;-6.74	5.47	5.47	0.80525	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99588	0.9851	L	0.48935	1.535	0.58432	D	0.999997	D;D;B;D;D;D;D	0.89917	0.985;0.999;0.303;0.997;0.999;1.0;1.0	P;D;B;D;D;D;D	0.87578	0.869;0.986;0.203;0.915;0.992;0.995;0.998	D	0.97925	1.0317	10	0.72032	D	0.01	-40.5855	17.1938	0.86887	0.0:1.0:0.0:0.0	.	141;180;180;87;180;180;180	B4E095;P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;.;P53_HUMAN;.;.	K	180;180;180;180;180;180;169;87;48;87;48	ENSP00000410739:E180K;ENSP00000352610:E180K;ENSP00000269305:E180K;ENSP00000398846:E180K;ENSP00000391127:E180K;ENSP00000391478:E180K;ENSP00000425104:E48K;ENSP00000423862:E87K	ENSP00000269305:E180K	E	-	1	0	TP53	7519117	1.000000	0.71417	0.986000	0.45419	0.845000	0.48019	4.918000	0.63376	2.735000	0.93741	0.563000	0.77884	GAG	False	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	0/1	NA	PASS	OTTHUMT00000367401.1	PASS		LUAD-TCGA-64-1681	PASS	PASS	NA	illumina	None	NA	0.477	TCGA-64-1681-01A-11D-2063-08		-	PASS	NA	1	1	145	214	2	473	23	24	0	47	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	17:7578392:T:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	M2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
EPN2	1	22905	broad.mit.edu	37	17	19216525	19216525	+	Silent	SNP	T	T	G			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	3813c301-9622-4567-bc72-d17acbeb236f	dde29d2e-09a2-4467-a8f4-2b1d37ce634a	g.chr17:19216525T>G	ENST00000395626.1	+	5	1221	c.1080T>G	c.(1078-1080)acT>acG	p.T360T	EPN2_ENST00000395618.3_Silent_p.T75T|EPN2_ENST00000575595.1_Silent_p.T68T|EPN2_ENST00000314728.5_Silent_p.T360T|EPN2_ENST00000395620.2_Silent_p.T303T|EPN2_ENST00000347697.2_Silent_p.T303T|EPN2_ENST00000571254.1_Silent_p.T296T			O95208	EPN2_HUMAN	epsin 2	360	6 X 3 AA repeats of [DE]-P-W.	NA		NA	endocytosis		lipid binding			breast(2)|endometrium(1)|kidney(3)|large_intestine(4)|lung(5)|prostate(1)|skin(2)|urinary_tract(1)	19	all_cancers(12;3.11e-05)|all_epithelial(12;0.00121)|Hepatocellular(7;0.00345)|Breast(13;0.143)					CAGCCTCCACTAACCAGACCA	0.632		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA	1						34	42	39	NA		NA	NA	17		NA											NA				19216525		2203	4300	6503	SO:0001819	synonymous_variant			1	ENSG00000072134	HGNC:18639	NM_014964	Approved	uc002gvd.4	ENST00000395626.1:c.1080T>G	chr17.hg19:g.19216525T>G		NA	NA	28.43	NA	NA	4052	9.59	O95207|Q9H7Z2|Q9UPT7	140,5	PASS	True	ENST00000395626.1	hg19		broad.mit.edu	PASS																																																																																			False	EPN2-004	PUTATIVE	basic|exp_conf	protein_coding	NA	protein_coding	0/1	NA	PASS	OTTHUMT00000132286.2	PASS		LUAD-TCGA-64-1681	PASS	PASS	NA	illumina	None	NA	0.036	TCGA-64-1681-01A-11D-2063-08		+	PASS	NA	1	0.9999819	66	735	0	625	6	148	0	115	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	17:19216525:G:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	M2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
F8	1	2157	broad.mit.edu	37	X	154133104	154133104	+	Nonsense_Mutation	SNP	A	A	C			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	3813c301-9622-4567-bc72-d17acbeb236f	dde29d2e-09a2-4467-a8f4-2b1d37ce634a	g.chrX:154133104A>C	ENST00000360256.4	-	16	5768	c.5568T>G	c.(5566-5568)taT>taG	p.Y1856*		NM_000132.3	NP_000123.1	P00451	FA8_HUMAN	coagulation factor VIII, procoagulant component	1856	F5/8 type A 3.|Plastocyanin-like 5.	NA		NA	acute-phase response|blood coagulation, intrinsic pathway|cell adhesion|platelet activation|platelet degranulation	extracellular space|plasma membrane|platelet alpha granule lumen	copper ion binding|oxidoreductase activity|protein binding			NS(1)|breast(3)|central_nervous_system(1)|cervix(1)|endometrium(9)|haematopoietic_and_lymphoid_tissue(3)|kidney(6)|large_intestine(27)|liver(1)|lung(47)|ovary(5)|pancreas(3)|prostate(1)|skin(5)|upper_aerodigestive_tract(5)|urinary_tract(2)	120	all_cancers(53;7.19e-17)|all_epithelial(53;9.83e-11)|all_lung(58;6.63e-07)|Lung NSC(58;2.08e-06)|all_hematologic(71;2.45e-06)|Acute lymphoblastic leukemia(192;6.56e-05)|Breast(217;0.176)|Renal(33;0.214)				Antihemophilic Factor(DB00025)|Coagulation Factor IX(DB00100)|Drotrecogin alfa(DB00055)	CATCAGAGAAATAAGCCCAGG	0.368		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			GRCh37	CM980704	F8	M	NA	1						114	93	100	NA		NA	NA	X		NA											NA				154133104		2203	4300	6503	SO:0001587	stop_gained			1	ENSG00000185010	HGNC:3546		Approved	uc004fmt.3	ENST00000360256.4:c.5568T>G	chrX.hg19:g.154133104A>C	unknown_prot_seq_id:p.Tyr1856*	NA	NA	33.1	NA	NA	4556	32.83	Q5HY69	141,14	PASS	True	ENST00000360256.4	hg19	CCDS35457.1	broad.mit.edu	PASS	.	.	.	.	.	.	.	.	.	.	A	46	12.917181	0.99706	.	.	ENSG00000185010	ENST00000360256	.	.	.	4.91	-0.314	0.12750	.	0.059749	0.64402	D	0.000002	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.02654	T	1	-16.4388	10.3232	0.43777	0.455:0.0:0.545:0.0	.	.	.	.	X	1856	.	ENSP00000353393:Y1856X	Y	-	3	2	F8	153786298	0.999000	0.42202	0.994000	0.49952	0.992000	0.81027	0.692000	0.25482	-0.351000	0.08249	0.412000	0.27726	TAT	False	F8-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	0/1	NA	PASS	OTTHUMT00000058869.4	PASS		LUAD-TCGA-64-1681	PASS	PASS	NA	illumina	None	NA	0.096	TCGA-64-1681-01A-11D-2063-08		-	PASS	NA	1	0.9999999	23	346	0	280	14	142	0	115	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	X:154133104:C:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	M2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ARID1A	1	8289	broad.mit.edu	37	1	27106069	27106069	+	Nonsense_Mutation	SNP	C	C	T			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	3813c301-9622-4567-bc72-d17acbeb236f	dde29d2e-09a2-4467-a8f4-2b1d37ce634a	g.chr1:27106069C>T	ENST00000457599.2	+	20	5029	c.5029C>T	c.(5029-5031)Cag>Tag	p.Q1677*	ARID1A_ENST00000324856.7_Nonsense_Mutation_p.Q1894*|ARID1A_ENST00000540690.1_Nonsense_Mutation_p.Q222*|ARID1A_ENST00000374152.2_Nonsense_Mutation_p.Q1511*	NM_139135.2	NP_624361.1	O14497	ARI1A_HUMAN	AT rich interactive domain 1A (SWI-like)	1894		NA		NA	androgen receptor signaling pathway|chromatin-mediated maintenance of transcription|estrogen receptor signaling pathway|glucocorticoid receptor signaling pathway|nervous system development|nucleosome mobilization|transcription, DNA-dependent	nBAF complex|npBAF complex|SWI/SNF complex	DNA binding|protein binding		ARID1A/MAST2_ENST00000361297(2)	NS(1)|autonomic_ganglia(1)|biliary_tract(1)|breast(13)|central_nervous_system(6)|cervix(2)|endometrium(56)|haematopoietic_and_lymphoid_tissue(8)|kidney(10)|large_intestine(41)|liver(31)|lung(34)|ovary(130)|pancreas(18)|prostate(8)|skin(9)|stomach(14)|upper_aerodigestive_tract(4)|urinary_tract(24)	411		all_cancers(24;6.36e-27)|all_epithelial(13;5.93e-24)|Colorectal(325;3.46e-05)|all_lung(284;4.76e-05)|Lung NSC(340;5.83e-05)|Breast(348;9.7e-05)|Renal(390;0.0007)|Ovarian(437;0.00473)|Myeloproliferative disorder(586;0.0255)|all_neural(195;0.0381)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|all cancers(4;2.61e-56)|Epithelial(14;7.53e-55)|OV - Ovarian serous cystadenocarcinoma(117;4.5e-30)|Colorectal(126;2.07e-09)|COAD - Colon adenocarcinoma(152;4.29e-07)|BRCA - Breast invasive adenocarcinoma(304;4.13e-05)|STAD - Stomach adenocarcinoma(196;0.000279)|KIRC - Kidney renal clear cell carcinoma(1967;0.000794)|GBM - Glioblastoma multiforme(114;0.0132)|READ - Rectum adenocarcinoma(331;0.0469)|Lung(427;0.167)|LUSC - Lung squamous cell carcinoma(448;0.242)		GACAACAGACCAGGAGGGGCC	0.597		NA	"""Mis, N, F, S, D"""		"""clear cell ovarian carcinoma, RCC"""		NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Rec	yes		1	1p35.3	8289	AT rich interactive domain 1A (SWI-like)	NA	E	0							NA	1						61	69	66	NA		NA	NA	1		NA											NA				27106069		2203	4300	6503	SO:0001587	stop_gained			1	ENSG00000117713	HGNC:11110	NM_139135	Approved	uc001bmv.1	ENST00000457599.2:c.5029C>T	chr1.hg19:g.27106069C>T	unknown_prot_seq_id:p.Gln1677*	NA	NA	31.55	NA	NA	2382	185.95	D3DPL1|Q53FK9|Q5T0W1|Q5T0W2|Q5T0W3|Q8NFD6|Q96T89|Q9BY33|Q9HBJ5|Q9UPZ1	73,65	PASS	True	ENST00000457599.2	hg19	CCDS44091.1	broad.mit.edu	PASS	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	40|40	8.510754|8.510754	0.98843|0.98843	.|.	.|.	ENSG00000117713|ENSG00000117713	ENST00000430799|ENST00000324856;ENST00000457599;ENST00000374152;ENST00000540690	.|.	.|.	.|.	4.84|4.84	3.85|3.85	0.44370|0.44370	.|.	.|0.407866	.|0.25938	.|N	.|0.027336	T|.	0.41949|.	0.1181|.	.|.	.|.	.|.	0.80722|0.80722	D|D	1|1	.|.	.|.	.|.	.|.	.|.	.|.	T|.	0.09552|.	-1.0669|.	4|.	.|0.10902	.|T	.|0.67	-6.0705|-6.0705	10.413|10.413	0.44305|0.44305	0.289:0.7109:0.0:0.0|0.289:0.7109:0.0:0.0	.|.	.|.	.|.	.|.	L|X	790|1894;1677;1511;222	.|.	.|ENSP00000320485:Q1894X	P|Q	+|+	2|1	0|0	ARID1A|ARID1A	26978656|26978656	0.991000|0.991000	0.36638|0.36638	0.999000|0.999000	0.59377|0.59377	0.682000|0.682000	0.39822|0.39822	1.933000|1.933000	0.40153|0.40153	2.667000|2.667000	0.90743|0.90743	0.491000|0.491000	0.48974|0.48974	CCA|CAG	False	ARID1A-002	NOVEL	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	0/1	NA	PASS	OTTHUMT00000011438.2	PASS		LUAD-TCGA-64-1681	PASS	PASS	NA	illumina	None	NA	0.481	TCGA-64-1681-01A-11D-2063-08		+	PASS	NA	1	1	340	441	0	817	66	73	0	120	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1:27106069:T:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	M2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HPS3	1	84343	broad.mit.edu	37	3	148858052	148858052	+	Intron	SNP	G	G	C			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	3813c301-9622-4567-bc72-d17acbeb236f	dde29d2e-09a2-4467-a8f4-2b1d37ce634a	g.chr3:148858052G>C	ENST00000460120.1	+	2	303				HPS3_ENST00000296051.2_Missense_Mutation_p.S160T			Q969F9	HPS3_HUMAN	Hermansky-Pudlak syndrome 3	NA		NA		NA		cytoplasm				breast(2)|endometrium(2)|kidney(1)|large_intestine(7)|lung(12)|ovary(5)|prostate(1)|skin(1)|upper_aerodigestive_tract(3)	34			LUSC - Lung squamous cell carcinoma(72;0.0473)|Lung(72;0.0607)			GTCTTATTTAGTTTGAAGTAC	0.378		NA					NA		Hermansky-Pudlak syndrome					NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA	1						118	118	118	NA		NA	NA	3		NA											NA				148858052		2203	4300	6503	SO:0001627	intron_variant	Familial Cancer Database	HPS, HPS1-8	1	ENSG00000163755	HGNC:15597	NM_032383	Approved	uc003ewu.1	ENST00000460120.1:c.218-752G>C	chr3.hg19:g.148858052G>C		NA	NA	36.72	NA	NA	1753	139.85	A8K6G6|Q8WTV6|Q96AP1|Q96MR3|Q9H608	51,48	PASS	True	ENST00000460120.1	hg19		broad.mit.edu	PASS	.	.	.	.	.	.	.	.	.	.	G	0.191	-1.053062	0.01965	.	.	ENSG00000163755	ENST00000296051	T	0.62639	0.01	5.37	2.33	0.28932	.	0.256492	0.42682	N	0.000676	T	0.38904	0.1058	N	0.17082	0.46	0.58432	D	0.999997	B	0.09022	0.002	B	0.13407	0.009	T	0.29027	-1.0025	10	0.02654	T	1	-8.3797	11.5564	0.50750	0.0697:0.5276:0.4027:0.0	.	160	Q969F9	HPS3_HUMAN	T	160	ENSP00000296051:S160T	ENSP00000296051:S160T	S	+	2	0	HPS3	150340742	1.000000	0.71417	0.484000	0.27391	0.222000	0.24845	1.727000	0.38095	0.178000	0.19917	-0.196000	0.12772	AGT	False	HPS3-003	NOVEL	basic|exp_conf	protein_coding	NA	protein_coding	0/1	NA	PASS	OTTHUMT00000356153.1	PASS		LUAD-TCGA-64-1681	PASS	PASS	NA	illumina	None	NA	0.467	TCGA-64-1681-01A-11D-2063-08		+	PASS	NA	1	1	174	144	0	401	48	51	0	128	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	3:148858052:C:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	M2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
DCAF4L1	1	285429	broad.mit.edu	37	4	41984513	41984513	+	Missense_Mutation	SNP	C	C	T			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	3813c301-9622-4567-bc72-d17acbeb236f	dde29d2e-09a2-4467-a8f4-2b1d37ce634a	g.chr4:41984513C>T	ENST00000333141.5	+	1	801	c.704C>T	c.(703-705)aCg>aTg	p.T235M		NM_001029955.3	NP_001025126.2	Q3SXM0	DC4L1_HUMAN	DDB1 and CUL4 associated factor 4-like 1	235		NA		NA						breast(1)|endometrium(5)|kidney(6)|large_intestine(11)|lung(12)|prostate(1)|skin(1)	37						TTTGCTAGTACGGCTCCTTTG	0.562		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA	1						157	152	154	NA		NA	NA	4		NA											NA				41984513		2203	4300	6503	SO:0001583	missense			38		HGNC:27723	NM_001029955	Approved	uc003gwk.2	ENST00000333141.5:c.704C>T	chr4.hg19:g.41984513C>T	unknown_prot_seq_id:p.Thr235Met	NA	NA	61.38	NA	NA	5168	57.17	B3KVI3|Q3ZCW8|Q499Y5|Q9UFI0	166,28	PASS	True	ENST00000333141.5	hg19	CCDS33978.1	broad.mit.edu	PASS	.	.	.	.	.	.	.	.	.	.	C	2.953	-0.216376	0.06101	.	.	ENSG00000182308	ENST00000333141	T	0.19806	2.12	0.688	-1.02	0.10135	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);	1.054160	0.07227	N	0.861930	T	0.07188	0.0182	N	0.03324	-0.35	0.09310	N	1	B	0.21071	0.051	B	0.04013	0.001	T	0.34601	-0.9822	10	0.20519	T	0.43	.	2.3984	0.04395	0.3222:0.354:0.3237:0.0	.	235	Q3SXM0	DC4L1_HUMAN	M	235	ENSP00000327796:T235M	ENSP00000327796:T235M	T	+	2	0	DCAF4L1	41679270	0.979000	0.34478	0.020000	0.16555	0.031000	0.12232	1.332000	0.33805	-0.381000	0.07882	0.313000	0.20887	ACG	False	DCAF4L1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	0/1	NA	PASS	OTTHUMT00000360958.1	PASS		LUAD-TCGA-64-1681	PASS	PASS	NA	illumina	None	NA	0.14	TCGA-64-1681-01A-11D-2063-08		+	PASS	NA	1	0.999999	16	119	0	217	29	170	0	236	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	4:41984513:T:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	M2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
F13A1	1	2162	broad.mit.edu	37	6	6145903	6145903	+	Silent	SNP	T	T	C			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	3813c301-9622-4567-bc72-d17acbeb236f	dde29d2e-09a2-4467-a8f4-2b1d37ce634a	g.chr6:6145903T>C	ENST00000264870.3	-	15	2413	c.2148A>G	c.(2146-2148)agA>agG	p.R716R		NM_000129.3	NP_000120.2	P00488	F13A_HUMAN	coagulation factor XIII, A1 polypeptide	716		NA		NA	peptide cross-linking|platelet activation|platelet degranulation	extracellular region|platelet alpha granule lumen	acyltransferase activity|metal ion binding|protein-glutamine gamma-glutamyltransferase activity			NS(1)|autonomic_ganglia(1)|breast(2)|central_nervous_system(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(10)|lung(37)|ovary(2)|pancreas(1)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)	62	Ovarian(93;0.0816)	all_hematologic(90;0.152)			L-Glutamine(DB00130)	CATACACATGTCTCAGGGAGT	0.552		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA	1						143	126	132	NA		NA	NA	6		NA											NA				6145903		2203	4300	6503	SO:0001819	synonymous_variant			4	ENSG00000124491	HGNC:3531		Approved	uc003mwv.3	ENST00000264870.3:c.2148A>G	chr6.hg19:g.6145903T>C		NA	NA	34.76	NA	NA	2467	30.84	Q59HA7|Q8N6X2|Q96P24|Q9BX29	78,13	PASS	True	ENST00000264870.3	hg19	CCDS4496.1	broad.mit.edu	PASS																																																																																			False	F13A1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	0/1	NA	PASS	OTTHUMT00000039756.3	PASS		LUAD-TCGA-64-1681	PASS	PASS	NA	illumina	None	NA	0.148	TCGA-64-1681-01A-11D-2063-08		-	PASS	NA	1	0.9999987	45	106	0	181	15	80	0	129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	6:6145903:C:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	M2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
EGFR	1	1956	broad.mit.edu	37	7	55259515	55259515	+	Missense_Mutation	SNP	T	T	G	rs121434568		LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	3813c301-9622-4567-bc72-d17acbeb236f	dde29d2e-09a2-4467-a8f4-2b1d37ce634a	g.chr7:55259515T>G	ENST00000455089.1	+	20	2695	c.2438T>G	c.(2437-2439)cTg>cGg	p.L813R	EGFR_ENST00000454757.2_Missense_Mutation_p.L805R|EGFR_ENST00000442591.1_Intron|EGFR_ENST00000275493.2_Missense_Mutation_p.L858R			P00533	EGFR_HUMAN	epidermal growth factor receptor	858	Protein kinase.	NA		NA	activation of phospholipase A2 activity by calcium-mediated signaling|activation of phospholipase C activity|axon guidance|cell proliferation|cell-cell adhesion|negative regulation of apoptosis|negative regulation of epidermal growth factor receptor signaling pathway|ossification|positive regulation of catenin import into nucleus|positive regulation of cell migration|positive regulation of cyclin-dependent protein kinase activity involved in G1/S|positive regulation of epithelial cell proliferation|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of phosphorylation|positive regulation of protein kinase B signaling cascade|protein autophosphorylation|protein insertion into membrane|regulation of nitric-oxide synthase activity|regulation of peptidyl-tyrosine phosphorylation|response to stress|response to UV-A	basolateral plasma membrane|endoplasmic reticulum membrane|endosome|extracellular space|Golgi membrane|integral to membrane|nuclear membrane|Shc-EGFR complex	actin filament binding|ATP binding|double-stranded DNA binding|epidermal growth factor receptor activity|identical protein binding|MAP/ERK kinase kinase activity|protein heterodimerization activity|protein phosphatase binding|receptor signaling protein tyrosine kinase activity	p.L858R(1489)|p.L858Q(1)|p.L858K(1)		NS(2)|adrenal_gland(5)|biliary_tract(8)|bone(3)|breast(18)|central_nervous_system(106)|endometrium(26)|eye(3)|haematopoietic_and_lymphoid_tissue(9)|kidney(11)|large_intestine(85)|liver(2)|lung(13575)|oesophagus(21)|ovary(38)|pancreas(3)|peritoneum(11)|pleura(2)|prostate(35)|salivary_gland(11)|skin(9)|small_intestine(1)|soft_tissue(4)|stomach(41)|thymus(2)|thyroid(14)|upper_aerodigestive_tract(59)|urinary_tract(6)	14110	all_cancers(1;1.57e-46)|all_epithelial(1;5.62e-37)|Lung NSC(1;9.29e-25)|all_lung(1;4.39e-23)|Esophageal squamous(2;7.55e-08)|Breast(14;0.0318)		GBM - Glioblastoma multiforme(1;0)|all cancers(1;2.19e-314)|Lung(13;4.65e-05)|LUSC - Lung squamous cell carcinoma(13;0.000168)|STAD - Stomach adenocarcinoma(5;0.00164)|Epithelial(13;0.0607)		Cetuximab(DB00002)|Erlotinib(DB00530)|Gefitinib(DB00317)|Lapatinib(DB01259)|Lidocaine(DB00281)|Panitumumab(DB01269)|Trastuzumab(DB00072)	GATTTTGGGCTGGCCAAACTG	0.537	L858R(NCIH1975_LUNG)	8	"""A, O, Mis"""		"""glioma, NSCLC"""	NSCLC	NA		Lung Cancer, Familial Clustering of	TCGA GBM(3;<1E-08)|TSP Lung(4;<1E-08)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Dom	yes	Familial lung cancer	7	7p12.3-p12.1	1956	"""epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)"""	NA	"""E, O"""	1491	Substitution - Missense(1491)	lung(1475)|upper_aerodigestive_tract(5)|thyroid(4)|large_intestine(2)|peritoneum(1)|stomach(1)|thymus(1)|breast(1)|ovary(1)					NA	1						105	98	101	NA		NA	NA	7		NA											NA				55259515		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	incl. Hereditary Lung cancer, Hereditary Non-Small Cell Lung cancer	4	ENSG00000146648	HGNC:3236	NM_005228	Approved	uc003tqk.3	ENST00000455089.1:c.2438T>G	chr7.hg19:g.55259515T>G	unknown_prot_seq_id:p.Leu813Arg	NA	NA	30.09	NA	NA	2888	99.52	O00688|O00732|P06268|Q14225|Q68GS5|Q92795|Q9BZS2|Q9GZX1|Q9H2C9|Q9H3C9|Q9UMD7|Q9UMD8|Q9UMG5	88,41	PASS	True	ENST00000455089.1	hg19		broad.mit.edu	PASS	.	.	.	.	.	.	.	.	.	.	T	25.1	4.601026	0.87055	.	.	ENSG00000146648	ENST00000455089;ENST00000395504;ENST00000275493;ENST00000454757	D;D;D	0.91351	-2.83;-2.83;-2.83	5.71	5.71	0.89125	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Tyrosine-protein kinase, catalytic domain (1);Protein kinase, catalytic domain (1);	0.137592	0.50627	D	0.000117	D	0.96340	0.8806	M	0.92555	3.32	0.58432	D	0.999999	D;D	0.89917	0.999;1.0	D;D	0.91635	0.956;0.999	D	0.97213	0.9872	10	0.87932	D	0	.	14.8112	0.69996	0.0:0.0:0.0:1.0	.	813;858	Q504U8;P00533	.;EGFR_HUMAN	R	813;728;858;805	ENSP00000415559:L813R;ENSP00000275493:L858R;ENSP00000395243:L805R	ENSP00000275493:L858R	L	+	2	0	EGFR	55227009	1.000000	0.71417	1.000000	0.80357	0.962000	0.63368	7.890000	0.87313	2.176000	0.68965	0.528000	0.53228	CTG	True	EGFR-004	PUTATIVE	basic|exp_conf	protein_coding	NA	protein_coding	0/1	NA	PASS	OTTHUMT00000343056.1	PASS	rs121434568	LUAD-TCGA-64-1681	PASS	PASS	NA	illumina	None	NA	0.321	TCGA-64-1681-01A-11D-2063-08		+	PASS	NA	1	1	96	271	0	415	42	88	1	113	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	7:55259515:G:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	M2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ABCD3	1	5825	broad.mit.edu	37	1	94982785	94982785	+	3'UTR	SNP	A	A	T	rs77888949	byFrequency|by1000genomes	LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	3813c301-9622-4567-bc72-d17acbeb236f	dde29d2e-09a2-4467-a8f4-2b1d37ce634a	g.chr1:94982785A>T	ENST00000370214.4	+	0	2104				ABCD3_ENST00000484213.1_3'UTR|ABCD3_ENST00000536817.1_3'UTR|ABCD3_ENST00000454898.2_3'UTR|ABCD3_ENST00000394233.2_3'UTR	NM_002858.3	NP_002849.1	P28288	ABCD3_HUMAN	ATP-binding cassette, sub-family D (ALD), member 3	NA		NA		NA	peroxisomal long-chain fatty acid import|peroxisome organization	cytosol|integral to peroxisomal membrane	ATP binding|ATPase activity, coupled to transmembrane movement of substances			breast(1)|endometrium(1)|kidney(3)|large_intestine(5)|liver(2)|lung(10)|ovary(1)|pancreas(1)|skin(2)	26		all_lung(203;0.000434)|Lung NSC(277;0.0019)		all cancers(265;0.0261)|Epithelial(280;0.165)		AGTTTTTTTTAAAAAAAAAAA	0.254		NA					NA						a	592	0.27	0.29	0.15	2184	0.39	0.9846	,	,	NA	0.0112	0.23	NA	NA	0.2724	0.9713	LOWCOV	NA	NA	3e-04	SNP						NA		NA		NA		0							NA	1						NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001624	3_prime_UTR_variant			1	ENSG00000117528	HGNC:67	NM_002858	Approved	uc001dqn.4	ENST00000370214.4:c.*100A>T	chr1.hg19:g.94982785A>T		NA	NA	10.53	NA	NA	735	8.1	D3DT46|Q15271|Q6NUN5|Q96DA3|Q9H529	24,4	PASS	True	ENST00000370214.4	hg19	CCDS749.1	broad.mit.edu	PASS																																																																																			True	ABCD3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	0/1	NA	PASS	OTTHUMT00000029597.1	PASS	rs662813	LUAD-TCGA-64-1681	PASS	PASS	NA	illumina	None	NA	0.138	TCGA-64-1681-01A-11D-2063-08		+	PASS	NA	1	0.9570947	8	117	2	137	4	26	0	36	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1:94982785:T:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	M2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ARID1A	NA	8289	broad.mit.edu	37	1	27106069	27106069	+	Nonsense_Mutation	SNP	C	C	T			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	g.chr1:27106069C>T	ENST00000324856.7	+	20	6051	c.5680C>T	c.(5680-5682)Cag>Tag	p.Q1894*	ARID1A_ENST00000457599.2_Nonsense_Mutation_p.Q1677*|ARID1A_ENST00000374152.2_Nonsense_Mutation_p.Q1511*|ARID1A_ENST00000540690.1_Nonsense_Mutation_p.Q222*	NM_006015.4	NP_006006.3	O14497	ARI1A_HUMAN	AT rich interactive domain 1A (SWI-like)	1894		NA		NA	androgen receptor signaling pathway|chromatin-mediated maintenance of transcription|estrogen receptor signaling pathway|glucocorticoid receptor signaling pathway|nervous system development|nucleosome mobilization|transcription, DNA-dependent	nBAF complex|npBAF complex|SWI/SNF complex	DNA binding|protein binding		ARID1A/MAST2_ENST00000361297(2)	NS(1)|autonomic_ganglia(1)|biliary_tract(1)|breast(13)|central_nervous_system(6)|cervix(2)|endometrium(56)|haematopoietic_and_lymphoid_tissue(8)|kidney(10)|large_intestine(41)|liver(31)|lung(34)|ovary(130)|pancreas(18)|prostate(8)|skin(9)|stomach(14)|upper_aerodigestive_tract(4)|urinary_tract(24)	411		all_cancers(24;6.36e-27)|all_epithelial(13;5.93e-24)|Colorectal(325;3.46e-05)|all_lung(284;4.76e-05)|Lung NSC(340;5.83e-05)|Breast(348;9.7e-05)|Renal(390;0.0007)|Ovarian(437;0.00473)|Myeloproliferative disorder(586;0.0255)|all_neural(195;0.0381)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|all cancers(4;2.61e-56)|Epithelial(14;7.53e-55)|OV - Ovarian serous cystadenocarcinoma(117;4.5e-30)|Colorectal(126;2.07e-09)|COAD - Colon adenocarcinoma(152;4.29e-07)|BRCA - Breast invasive adenocarcinoma(304;4.13e-05)|STAD - Stomach adenocarcinoma(196;0.000279)|KIRC - Kidney renal clear cell carcinoma(1967;0.000794)|GBM - Glioblastoma multiforme(114;0.0132)|READ - Rectum adenocarcinoma(331;0.0469)|Lung(427;0.167)|LUSC - Lung squamous cell carcinoma(448;0.242)		GACAACAGACCAGGAGGGGCC	0.597		NA	"""Mis, N, F, S, D"""		"""clear cell ovarian carcinoma, RCC"""		NA				NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	1	340	441	0	817	66	73	0	120	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1:27106069:T:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	MI		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Rec	yes		1	1p35.3	8289	AT rich interactive domain 1A (SWI-like)	NA	E	0							NA						61	69	66	NA		NA	NA	1		NA											NA				27106069		2203	4300	6503	SO:0001587	stop_gained			ENSG00000117713	HGNC:11110	NM_139135	Approved	uc001bmv.1	ENST00000324856.7:c.5680C>T	1.37:g.27106069C>T	ENSP00000320485:p.Gln1894*	NA	D3DPL1|Q53FK9|Q5T0W1|Q5T0W2|Q5T0W3|Q8NFD6|Q96T89|Q9BY33|Q9HBJ5|Q9UPZ1	ENST00000324856.7	37	CCDS285.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	40|40	8.510754|8.510754	0.98843|0.98843	.|.	.|.	ENSG00000117713|ENSG00000117713	ENST00000430799|ENST00000324856;ENST00000457599;ENST00000374152;ENST00000540690	.|.	.|.	.|.	4.84|4.84	3.85|3.85	0.44370|0.44370	.|.	.|0.407866	.|0.25938	.|N	.|0.027336	T|.	0.41949|.	0.1181|.	.|.	.|.	.|.	0.80722|0.80722	D|D	1|1	.|.	.|.	.|.	.|.	.|.	.|.	T|.	0.09552|.	-1.0669|.	4|.	.|0.10902	.|T	.|0.67	-6.0705|-6.0705	10.413|10.413	0.44305|0.44305	0.289:0.7109:0.0:0.0|0.289:0.7109:0.0:0.0	.|.	.|.	.|.	.|.	L|X	790|1894;1677;1511;222	.|.	.|ENSP00000320485:Q1894X	P|Q	+|+	2|1	0|0	ARID1A|ARID1A	26978656|26978656	0.991000|0.991000	0.36638|0.36638	0.999000|0.999000	0.59377|0.59377	0.682000|0.682000	0.39822|0.39822	1.933000|1.933000	0.40153|0.40153	2.667000|2.667000	0.90743|0.90743	0.491000|0.491000	0.48974|0.48974	CCA|CAG	ARID1A-001	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000011437.2	190.389766	KEEP		+	190.41623	0.484848	64	68	---	---	---	---	NA	NA	NA
ABCD3	NA	5825	broad.mit.edu	37	1	94982785	94982785	+	3'UTR	SNP	A	A	T	rs77888949	byFrequency|by1000genomes	LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	g.chr1:94982785A>T	ENST00000370214.4	+	0	2104				ABCD3_ENST00000484213.1_3'UTR|ABCD3_ENST00000454898.2_3'UTR|ABCD3_ENST00000536817.1_3'UTR|ABCD3_ENST00000394233.2_3'UTR	NM_002858.3	NP_002849.1	P28288	ABCD3_HUMAN	ATP-binding cassette, sub-family D (ALD), member 3	NA		NA		NA	peroxisomal long-chain fatty acid import|peroxisome organization	cytosol|integral to peroxisomal membrane	ATP binding|ATPase activity, coupled to transmembrane movement of substances			breast(1)|endometrium(1)|kidney(3)|large_intestine(5)|liver(2)|lung(10)|ovary(1)|pancreas(1)|skin(2)	26		all_lung(203;0.000434)|Lung NSC(277;0.0019)		all cancers(265;0.0261)|Epithelial(280;0.165)		AGTTTTTTTTAAAAAAAAAAA	0.254		NA					NA				NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	0.9570947	8	117	2	137	4	26	0	36	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1:94982785:T:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	MI	a	592	0.27	0.29	0.15	2184	0.39	0.9846	,	,	NA	0.0112	0.23	NA	NA	0.2724	0.9713	LOWCOV	NA	NA	3e-04	SNP						NA		NA		NA		0							NA						NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001624	3_prime_UTR_variant			ENSG00000117528	HGNC:67	NM_002858	Approved	uc001dqn.4	ENST00000370214.4:c.*100A>T	1.37:g.94982785A>T		NA	D3DT46|Q15271|Q6NUN5|Q96DA3|Q9H529	ENST00000370214.4	37	CCDS749.1																																																																																			ABCD3-001	KNOWN	basic|appris_principal|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000029597.1	5.481999	KEEP		+	8.923775	0.142857	4	24	---	---	---	---	NA	NA	NA
HPS3	NA	84343	broad.mit.edu	37	3	148858052	148858052	+	Missense_Mutation	SNP	G	G	C			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	g.chr3:148858052G>C	ENST00000296051.2	+	2	619	c.479G>C	c.(478-480)aGt>aCt	p.S160T	HPS3_ENST00000460120.1_Intron	NM_032383.3	NP_115759.2	Q969F9	HPS3_HUMAN	Hermansky-Pudlak syndrome 3	160		NA		NA		cytoplasm				breast(2)|endometrium(2)|kidney(1)|large_intestine(7)|lung(12)|ovary(5)|prostate(1)|skin(1)|upper_aerodigestive_tract(3)	34			LUSC - Lung squamous cell carcinoma(72;0.0473)|Lung(72;0.0607)			GTCTTATTTAGTTTGAAGTAC	0.378		NA					NA		Hermansky-Pudlak syndrome		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	1	174	144	0	401	48	51	0	128	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	3:148858052:C:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	MI		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						118	118	118	NA		NA	NA	3		NA											NA				148858052		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	HPS, HPS1-8	ENSG00000163755	HGNC:15597	NM_032383	Approved	uc003ewu.1	ENST00000296051.2:c.479G>C	3.37:g.148858052G>C	ENSP00000296051:p.Ser160Thr	NA	A8K6G6|Q8WTV6|Q96AP1|Q96MR3|Q9H608	ENST00000296051.2	37	CCDS3140.1	.	.	.	.	.	.	.	.	.	.	G	0.191	-1.053062	0.01965	.	.	ENSG00000163755	ENST00000296051	T	0.62639	0.01	5.37	2.33	0.28932	.	0.256492	0.42682	N	0.000676	T	0.38904	0.1058	N	0.17082	0.46	0.58432	D	0.999997	B	0.09022	0.002	B	0.13407	0.009	T	0.29027	-1.0025	10	0.02654	T	1	-8.3797	11.5564	0.50750	0.0697:0.5276:0.4027:0.0	.	160	Q969F9	HPS3_HUMAN	T	160	ENSP00000296051:S160T	ENSP00000296051:S160T	S	+	2	0	HPS3	150340742	1.000000	0.71417	0.484000	0.27391	0.222000	0.24845	1.727000	0.38095	0.178000	0.19917	-0.196000	0.12772	AGT	HPS3-001	KNOWN	basic|appris_principal|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000356151.1	140.946776	KEEP		+	141.007689	0.47191	42	47	---	---	---	---	NA	NA	NA
DCAF4L1	NA	285429	broad.mit.edu	37	4	41984513	41984513	+	Missense_Mutation	SNP	C	C	T			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	g.chr4:41984513C>T	ENST00000333141.5	+	1	801	c.704C>T	c.(703-705)aCg>aTg	p.T235M		NM_001029955.3	NP_001025126.2	Q3SXM0	DC4L1_HUMAN	DDB1 and CUL4 associated factor 4-like 1	235		NA		NA						breast(1)|endometrium(5)|kidney(6)|large_intestine(11)|lung(12)|prostate(1)|skin(1)	37						TTTGCTAGTACGGCTCCTTTG	0.562		NA					NA				NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	0.999999	16	119	0	217	29	170	0	236	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	4:41984513:T:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	MI		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						157	152	154	NA		NA	NA	4		NA											NA				41984513		2203	4300	6503	SO:0001583	missense				HGNC:27723	NM_001029955	Approved	uc003gwk.2	ENST00000333141.5:c.704C>T	4.37:g.41984513C>T	ENSP00000327796:p.Thr235Met	NA	B3KVI3|Q3ZCW8|Q499Y5|Q9UFI0	ENST00000333141.5	37	CCDS33978.1	.	.	.	.	.	.	.	.	.	.	C	2.953	-0.216376	0.06101	.	.	ENSG00000182308	ENST00000333141	T	0.19806	2.12	0.688	-1.02	0.10135	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);	1.054160	0.07227	N	0.861930	T	0.07188	0.0182	N	0.03324	-0.35	0.09310	N	1	B	0.21071	0.051	B	0.04013	0.001	T	0.34601	-0.9822	10	0.20519	T	0.43	.	2.3984	0.04395	0.3222:0.354:0.3237:0.0	.	235	Q3SXM0	DC4L1_HUMAN	M	235	ENSP00000327796:T235M	ENSP00000327796:T235M	T	+	2	0	DCAF4L1	41679270	0.979000	0.34478	0.020000	0.16555	0.031000	0.12232	1.332000	0.33805	-0.381000	0.07882	0.313000	0.20887	ACG	DCAF4L1-001	KNOWN	basic|appris_principal|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000360958.1	35.485585	KEEP		+	57.313608	0.138728	24	149	---	---	---	---	NA	NA	NA
F13A1	NA	2162	broad.mit.edu	37	6	6145903	6145903	+	Silent	SNP	T	T	C			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	g.chr6:6145903T>C	ENST00000264870.3	-	15	2413	c.2148A>G	c.(2146-2148)agA>agG	p.R716R		NM_000129.3	NP_000120.2	P00488	F13A_HUMAN	coagulation factor XIII, A1 polypeptide	716		NA		NA	peptide cross-linking|platelet activation|platelet degranulation	extracellular region|platelet alpha granule lumen	acyltransferase activity|metal ion binding|protein-glutamine gamma-glutamyltransferase activity			NS(1)|autonomic_ganglia(1)|breast(2)|central_nervous_system(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(10)|lung(37)|ovary(2)|pancreas(1)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)	62	Ovarian(93;0.0816)	all_hematologic(90;0.152)			L-Glutamine(DB00130)	CATACACATGTCTCAGGGAGT	0.552		NA					NA				NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	0.9999987	45	106	0	181	15	80	0	129	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	6:6145903:C:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	MI		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						143	126	132	NA		NA	NA	6		NA											NA				6145903		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000124491	HGNC:3531		Approved	uc003mwv.3	ENST00000264870.3:c.2148A>G	6.37:g.6145903T>C		NA	Q59HA7|Q8N6X2|Q96P24|Q9BX29	ENST00000264870.3	37	CCDS4496.1																																																																																			F13A1-001	KNOWN	basic|appris_principal|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000039756.3	25.421106	KEEP		-	34.537742	0.158537	13	69	---	---	---	---	NA	NA	NA
EGFR	NA	1956	broad.mit.edu	37	7	55259515	55259515	+	Missense_Mutation	SNP	T	T	G	rs121434568		LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	g.chr7:55259515T>G	ENST00000275493.2	+	21	2750	c.2573T>G	c.(2572-2574)cTg>cGg	p.L858R	EGFR_ENST00000455089.1_Missense_Mutation_p.L813R|EGFR_ENST00000442591.1_Intron|EGFR_ENST00000454757.2_Missense_Mutation_p.L805R	NM_005228.3	NP_005219.2	P00533	EGFR_HUMAN	epidermal growth factor receptor	858	Protein kinase.	NA	L -> M (found in a lung cancer sample).|L -> R (found in a lung cancer sample; somatic mutation; constitutively activated enzyme with strongly increased kinase activity).	NA	activation of phospholipase A2 activity by calcium-mediated signaling|activation of phospholipase C activity|axon guidance|cell proliferation|cell-cell adhesion|negative regulation of apoptosis|negative regulation of epidermal growth factor receptor signaling pathway|ossification|positive regulation of catenin import into nucleus|positive regulation of cell migration|positive regulation of cyclin-dependent protein kinase activity involved in G1/S|positive regulation of epithelial cell proliferation|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of phosphorylation|positive regulation of protein kinase B signaling cascade|protein autophosphorylation|protein insertion into membrane|regulation of nitric-oxide synthase activity|regulation of peptidyl-tyrosine phosphorylation|response to stress|response to UV-A	basolateral plasma membrane|endoplasmic reticulum membrane|endosome|extracellular space|Golgi membrane|integral to membrane|nuclear membrane|Shc-EGFR complex	actin filament binding|ATP binding|double-stranded DNA binding|epidermal growth factor receptor activity|identical protein binding|MAP/ERK kinase kinase activity|protein heterodimerization activity|protein phosphatase binding|receptor signaling protein tyrosine kinase activity	p.L858R(1489)|p.L858Q(1)|p.L858K(1)		NS(2)|adrenal_gland(5)|biliary_tract(8)|bone(3)|breast(18)|central_nervous_system(106)|endometrium(26)|eye(3)|haematopoietic_and_lymphoid_tissue(9)|kidney(11)|large_intestine(85)|liver(2)|lung(13575)|oesophagus(21)|ovary(38)|pancreas(3)|peritoneum(11)|pleura(2)|prostate(35)|salivary_gland(11)|skin(9)|small_intestine(1)|soft_tissue(4)|stomach(41)|thymus(2)|thyroid(14)|upper_aerodigestive_tract(59)|urinary_tract(6)	14110	all_cancers(1;1.57e-46)|all_epithelial(1;5.62e-37)|Lung NSC(1;9.29e-25)|all_lung(1;4.39e-23)|Esophageal squamous(2;7.55e-08)|Breast(14;0.0318)		GBM - Glioblastoma multiforme(1;0)|all cancers(1;2.19e-314)|Lung(13;4.65e-05)|LUSC - Lung squamous cell carcinoma(13;0.000168)|STAD - Stomach adenocarcinoma(5;0.00164)|Epithelial(13;0.0607)		Cetuximab(DB00002)|Erlotinib(DB00530)|Gefitinib(DB00317)|Lapatinib(DB01259)|Lidocaine(DB00281)|Panitumumab(DB01269)|Trastuzumab(DB00072)	GATTTTGGGCTGGCCAAACTG	0.537	L858R(NCIH1975_LUNG)	8	"""A, O, Mis"""		"""glioma, NSCLC"""	NSCLC	NA		Lung Cancer, Familial Clustering of	TCGA GBM(3;<1E-08)|TSP Lung(4;<1E-08)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	1	96	271	0	415	42	88	1	113	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	7:55259515:G:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	MI		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Dom	yes	Familial lung cancer	7	7p12.3-p12.1	1956	"""epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)"""	NA	"""E, O"""	1491	Substitution - Missense(1491)	lung(1475)|upper_aerodigestive_tract(5)|thyroid(4)|large_intestine(2)|peritoneum(1)|stomach(1)|thymus(1)|breast(1)|ovary(1)					NA						105	98	101	NA		NA	NA	7		NA											NA				55259515		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	incl. Hereditary Lung cancer, Hereditary Non-Small Cell Lung cancer	ENSG00000146648	HGNC:3236	NM_005228	Approved	uc003tqk.3	ENST00000275493.2:c.2573T>G	7.37:g.55259515T>G	ENSP00000275493:p.Leu858Arg	NA	O00688|O00732|P06268|Q14225|Q68GS5|Q92795|Q9BZS2|Q9GZX1|Q9H2C9|Q9H3C9|Q9UMD7|Q9UMD8|Q9UMG5	ENST00000275493.2	37	CCDS5514.1	.	.	.	.	.	.	.	.	.	.	T	25.1	4.601026	0.87055	.	.	ENSG00000146648	ENST00000455089;ENST00000395504;ENST00000275493;ENST00000454757	D;D;D	0.91351	-2.83;-2.83;-2.83	5.71	5.71	0.89125	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Tyrosine-protein kinase, catalytic domain (1);Protein kinase, catalytic domain (1);	0.137592	0.50627	D	0.000117	D	0.96340	0.8806	M	0.92555	3.32	0.58432	D	0.999999	D;D	0.89917	0.999;1.0	D;D	0.91635	0.956;0.999	D	0.97213	0.9872	10	0.87932	D	0	.	14.8112	0.69996	0.0:0.0:0.0:1.0	.	813;858	Q504U8;P00533	.;EGFR_HUMAN	R	813;728;858;805	ENSP00000415559:L813R;ENSP00000275493:L858R;ENSP00000395243:L805R	ENSP00000275493:L858R	L	+	2	0	EGFR	55227009	1.000000	0.71417	1.000000	0.80357	0.962000	0.63368	7.890000	0.87313	2.176000	0.68965	0.528000	0.53228	CTG	EGFR-001	KNOWN	basic|appris_principal|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000251456.2	98.242536	KEEP		+	101.293281	0.324324	36	75	---	---	---	---	NA	NA	NA
OR8I2	NA	120586	broad.mit.edu	37	11	55861485	55861485	+	Silent	SNP	G	G	A			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	g.chr11:55861485G>A	ENST00000302124.2	+	1	733	c.702G>A	c.(700-702)caG>caA	p.Q234Q		NM_001003750.1	NP_001003750.1	Q8N0Y5	OR8I2_HUMAN	olfactory receptor, family 8, subfamily I, member 2	234		NA		NA	sensory perception of smell	integral to membrane|plasma membrane	olfactory receptor activity			NS(1)|breast(2)|endometrium(16)|haematopoietic_and_lymphoid_tissue(2)|large_intestine(4)|lung(24)|ovary(1)|skin(2)|upper_aerodigestive_tract(1)	53	Esophageal squamous(21;0.00693)					CAGGCAGGCAGAAGGCCTTCT	0.468		NA					NA				NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	0.9996837	14	92	0	86	15	111	0	128	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	11:55861485:A:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	MI		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						152	138	143	NA		NA	NA	11		NA											NA				55861485		2201	4296	6497	SO:0001819	synonymous_variant			ENSG00000172154	HGNC:15310	NM_001003750	Approved	uc010rix.2	ENST00000302124.2:c.702G>A	11.37:g.55861485G>A		NA	B2RNN4|Q6IFC0|Q96RC5	ENST00000302124.2	37	CCDS31517.1																																																																																			OR8I2-201	KNOWN	basic|appris_principal|CCDS	protein_coding	NA	protein_coding		14.397029	KEEP		+	31.139874	0.114035	13	101	---	---	---	---	NA	NA	NA
ATM	NA	472	broad.mit.edu	37	11	108139190	108139190	+	Missense_Mutation	SNP	T	T	G			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	g.chr11:108139190T>G	ENST00000278616.4	+	18	3077	c.2692T>G	c.(2692-2694)Tta>Gta	p.L898V	ATM_ENST00000452508.2_Missense_Mutation_p.L898V	NM_000051.3	NP_000042	Q13315	ATM_HUMAN	ataxia telangiectasia mutated	898		NA		NA	cell cycle arrest|cellular response to gamma radiation|DNA damage induced protein phosphorylation|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|double-strand break repair via homologous recombination|G2/M transition DNA damage checkpoint|histone mRNA catabolic process|mitotic cell cycle spindle assembly checkpoint|negative regulation of B cell proliferation|peptidyl-serine phosphorylation|positive regulation of DNA damage response, signal transduction by p53 class mediator|pre-B cell allelic exclusion|protein autophosphorylation|reciprocal meiotic recombination|replicative senescence	cytoplasmic membrane-bounded vesicle|nucleoplasm	1-phosphatidylinositol-3-kinase activity|ATP binding|DNA binding|DNA-dependent protein kinase activity|identical protein binding|protein complex binding|protein dimerization activity|protein N-terminus binding			NS(4)|breast(23)|central_nervous_system(11)|endometrium(10)|haematopoietic_and_lymphoid_tissue(227)|kidney(19)|large_intestine(53)|liver(5)|lung(62)|ovary(6)|pancreas(4)|prostate(13)|skin(4)|stomach(1)|upper_aerodigestive_tract(3)|urinary_tract(3)	448		all_cancers(61;9.64e-12)|all_epithelial(67;9.97e-08)|Melanoma(852;2.55e-06)|Acute lymphoblastic leukemia(157;3.95e-05)|all_hematologic(158;0.00014)|Breast(348;0.0258)|all_neural(303;0.072)		Epithelial(105;9.05e-06)|BRCA - Breast invasive adenocarcinoma(274;1.06e-05)|all cancers(92;0.000208)|Colorectal(284;0.116)|OV - Ovarian serous cystadenocarcinoma(223;0.147)		TCTACTTTTCTTAGACATGCT	0.373		NA	"""D, Mis, N, F, S"""		T-PLL	"""leukemia, lymphoma, medulloblastoma, glioma"""	NA	Genes defective in diseases associated with sensitivity to DNA damaging agents	Ataxia Telangiectasia	TSP Lung(14;0.12)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	1	37	260	0	501	20	138	0	231	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	11:108139190:G:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	MI		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Rec	yes	Ataxia-telangiectasia	11	11q22.3	472	ataxia telangiectasia mutated	NA	"""L, O"""	0							NA						215	213	213	NA		NA	NA	11		NA											NA				108139190		2201	4298	6499	SO:0001583	missense	Familial Cancer Database	AT, Louis-Bar syndrome	ENSG00000149311	HGNC:795	NM_000051	Approved	uc001pkb.1	ENST00000278616.4:c.2692T>G	11.37:g.108139190T>G	ENSP00000278616:p.Leu898Val	NA	B2RNX5|O15429|Q12758|Q16551|Q93007|Q9NP02|Q9UCX7	ENST00000278616.4	37	CCDS31669.1	.	.	.	.	.	.	.	.	.	.	T	16.88	3.244705	0.59103	.	.	ENSG00000149311	ENST00000527805;ENST00000278616;ENST00000452508	T;T;T	0.80824	-1.42;-1.42;-1.42	5.96	3.63	0.41609	Armadillo-type fold (1);	0.000000	0.64402	D	0.000001	T	0.79811	0.4510	M	0.72894	2.215	0.35721	D	0.817167	D	0.59357	0.985	P	0.49665	0.618	T	0.81230	-0.1027	10	0.41790	T	0.15	.	4.599	0.12343	0.0:0.4259:0.0:0.5741	.	898	Q13315	ATM_HUMAN	V	898	ENSP00000435747:L898V;ENSP00000278616:L898V;ENSP00000388058:L898V	ENSP00000278616:L898V	L	+	1	2	ATM	107644400	0.999000	0.42202	0.824000	0.32777	0.809000	0.45718	3.245000	0.51407	1.075000	0.40932	0.533000	0.62120	TTA	ATM-201	KNOWN	basic|appris_principal|CCDS	protein_coding	NA	protein_coding		29.257712	KEEP		+	46.160236	0.136364	18	114	---	---	---	---	NA	NA	NA
SIN3A	NA	25942	broad.mit.edu	37	15	75714964	75714964	+	Nonsense_Mutation	SNP	C	C	T			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	g.chr15:75714964C>T	ENST00000567289.1	-	3	664	c.390G>A	c.(388-390)tgG>tgA	p.W130*	SIN3A_ENST00000360439.4_Intron|SIN3A_ENST00000394947.3_Intron|SIN3A_ENST00000394949.4_Intron			Q96ST3	SIN3A_HUMAN	SIN3 transcription regulator family member A	517	Interaction with HCFC1.|PAH 1.	NA		NA	blood coagulation|cellular lipid metabolic process|negative regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleolus|Sin3 complex	protein binding			breast(2)|central_nervous_system(1)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(16)|lung(15)|ovary(3)|prostate(2)|skin(5)|upper_aerodigestive_tract(2)	63						ATTTTTTGACCCAAGAAAAAG	0.458		NA					NA				NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	0.9426475	8	31	0	58	8	57	0	91	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	15:75714964:T:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	MI		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						59	62	61	NA		NA	NA	15		NA											NA				75714964		2197	4294	6491	SO:0001587	stop_gained			ENSG00000169375	HGNC:19353	NM_015477	Approved	uc002bai.3	ENST00000567289.1:c.390G>A	15.37:g.75714964C>T	ENSP00000455834:p.Trp130*	NA	B2RNS5|Q8N8N4|Q8NC83|Q8WV18|Q96L98|Q9UFQ1	ENST00000567289.1	37																																																																																				SIN3A-003	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000420314.1	12.157883	KEEP		-	19.987493	0.133333	8	52	---	---	---	---	NA	NA	NA
TP53	NA	7157	broad.mit.edu	37	17	7578392	7578392	+	Missense_Mutation	SNP	C	C	T			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	g.chr17:7578392C>T	ENST00000420246.2	-	5	670	c.538G>A	c.(538-540)Gag>Aag	p.E180K	TP53_ENST00000455263.2_Missense_Mutation_p.E180K|TP53_ENST00000413465.2_Missense_Mutation_p.E180K|TP53_ENST00000445888.2_Missense_Mutation_p.E180K|TP53_ENST00000574684.1_5'UTR|TP53_ENST00000359597.4_Missense_Mutation_p.E180K|TP53_ENST00000269305.4_Missense_Mutation_p.E180K	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	180	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42.	NA	E -> A (in a sporadic cancer; somatic mutation).|E -> D (in sporadic cancers; somatic mutation).|E -> G (in a sporadic cancer; somatic mutation).|E -> K (in LFS; germline mutation and in sporadic cancers; somatic mutation).|E -> Q (in sporadic cancers; somatic mutation).|E -> V (in a sporadic cancer; somatic mutation).	NA	activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.E180*(14)|p.P177_C182delPHHERC(8)|p.0?(8)|p.E180K(5)|p.C176_R181delCPHHER(3)|p.R174fs*24(3)|p.H178_S183delHHERCS(3)|p.R175_E180delRCPHHE(3)|p.P177fs*3(2)|p.V173fs*59(2)|p.C176fs*65(1)|p.V173fs*23(1)|p.V172_E180delVVRRCPHHE(1)|p.E180Q(1)|p.R81fs*24(1)|p.E180>DGRCPHQ(1)|p.R174_E180>K(1)|p.H46_S51delHHERCS(1)|p.H178fs*6(1)|p.P177_E180delPHHE(1)|p.R42fs*24(1)|p.H85_S90delHHERCS(1)|p.R174fs*3(1)|p.E180fs*6(1)|p.E171fs*61(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GAGCAGCGCTCATGGTGGGGG	0.637		111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""	NA	Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	1	145	214	2	473	23	24	0	47	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	17:7578392:T:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	MI		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53	NA	"""L, E, M, O"""	66	Deletion - In frame(21)|Substitution - Nonsense(14)|Deletion - Frameshift(14)|Whole gene deletion(8)|Substitution - Missense(6)|Insertion - Frameshift(1)|Complex - insertion inframe(1)|Complex - deletion inframe(1)	large_intestine(16)|upper_aerodigestive_tract(9)|urinary_tract(6)|breast(6)|lung(5)|oesophagus(4)|bone(4)|central_nervous_system(3)|haematopoietic_and_lymphoid_tissue(3)|ovary(3)|stomach(2)|liver(2)|pancreas(2)|prostate(1)	GRCh37	CM941328	TP53	M	NA						47	47	47	NA		NA	NA	17		NA											NA				7578392		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	ENST00000420246.2:c.538G>A	17.37:g.7578392C>T	ENSP00000391127:p.Glu180Lys	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	C	26.1	4.704841	0.88924	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000509690;ENST00000514944;ENST00000414315	D;D;D;D;D;D;D;D	0.99784	-6.74;-6.74;-6.74;-6.74;-6.74;-6.74;-6.74;-6.74	5.47	5.47	0.80525	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99588	0.9851	L	0.48935	1.535	0.58432	D	0.999997	D;D;B;D;D;D;D	0.89917	0.985;0.999;0.303;0.997;0.999;1.0;1.0	P;D;B;D;D;D;D	0.87578	0.869;0.986;0.203;0.915;0.992;0.995;0.998	D	0.97925	1.0317	10	0.72032	D	0.01	-40.5855	17.1938	0.86887	0.0:1.0:0.0:0.0	.	141;180;180;87;180;180;180	B4E095;P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;.;P53_HUMAN;.;.	K	180;180;180;180;180;180;169;87;48;87;48	ENSP00000410739:E180K;ENSP00000352610:E180K;ENSP00000269305:E180K;ENSP00000398846:E180K;ENSP00000391127:E180K;ENSP00000391478:E180K;ENSP00000425104:E48K;ENSP00000423862:E87K	ENSP00000269305:E180K	E	-	1	0	TP53	7519117	1.000000	0.71417	0.986000	0.45419	0.845000	0.48019	4.918000	0.63376	2.735000	0.93741	0.563000	0.77884	GAG	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	61.970607	KEEP		-	61.990467	0.477273	21	23	---	---	---	---	NA	NA	NA
F8	NA	2157	broad.mit.edu	37	X	154133104	154133104	+	Nonsense_Mutation	SNP	A	A	C			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	g.chrX:154133104A>C	ENST00000360256.4	-	16	5768	c.5568T>G	c.(5566-5568)taT>taG	p.Y1856*		NM_000132.3	NP_000123.1	P00451	FA8_HUMAN	coagulation factor VIII, procoagulant component	1856	F5/8 type A 3.|Plastocyanin-like 5.	NA		NA	acute-phase response|blood coagulation, intrinsic pathway|cell adhesion|platelet activation|platelet degranulation	extracellular space|plasma membrane|platelet alpha granule lumen	copper ion binding|oxidoreductase activity|protein binding			NS(1)|breast(3)|central_nervous_system(1)|cervix(1)|endometrium(9)|haematopoietic_and_lymphoid_tissue(3)|kidney(6)|large_intestine(27)|liver(1)|lung(47)|ovary(5)|pancreas(3)|prostate(1)|skin(5)|upper_aerodigestive_tract(5)|urinary_tract(2)	120	all_cancers(53;7.19e-17)|all_epithelial(53;9.83e-11)|all_lung(58;6.63e-07)|Lung NSC(58;2.08e-06)|all_hematologic(71;2.45e-06)|Acute lymphoblastic leukemia(192;6.56e-05)|Breast(217;0.176)|Renal(33;0.214)				Antihemophilic Factor(DB00025)|Coagulation Factor IX(DB00100)|Drotrecogin alfa(DB00055)	CATCAGAGAAATAAGCCCAGG	0.368		NA					NA				NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	0.9999999	23	346	0	280	14	142	0	115	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	X:154133104:C:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	MI		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			GRCh37	CM980704	F8	M	NA						114	93	100	NA		NA	NA	X		NA											NA				154133104		2203	4300	6503	SO:0001587	stop_gained			ENSG00000185010	HGNC:3546		Approved	uc004fmt.3	ENST00000360256.4:c.5568T>G	X.37:g.154133104A>C	ENSP00000353393:p.Tyr1856*	NA	Q5HY69	ENST00000360256.4	37	CCDS35457.1	.	.	.	.	.	.	.	.	.	.	A	46	12.917181	0.99706	.	.	ENSG00000185010	ENST00000360256	.	.	.	4.91	-0.314	0.12750	.	0.059749	0.64402	D	0.000002	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.02654	T	1	-16.4388	10.3232	0.43777	0.455:0.0:0.545:0.0	.	.	.	.	X	1856	.	ENSP00000353393:Y1856X	Y	-	3	2	F8	153786298	0.999000	0.42202	0.994000	0.49952	0.992000	0.81027	0.692000	0.25482	-0.351000	0.08249	0.412000	0.27726	TAT	F8-001	KNOWN	basic|appris_principal|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000058869.4	10.771613	KEEP		-	33.085984	0.095588	13	123	---	---	---	---	NA	NA	NA
HNRNPKP3	NA	0	broad.mit.edu	37	11	43283605	43283606	+	RNA	INS	-	-	A			LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-64-1681-Tumor-SM-2HMQE	LUAD-TCGA-64-1681-Normal-SM-2HMQ2	g.chr11:43283605_43283606insA	ENST00000511537.1	-	0	1329_1330					NR_033868.1					NA		NA	NA	NA				NA			NA						GAAGCAAATGTAAAAAAAAAAA	0.386	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	0.9120356	5	341	12	233	3	7	0	9	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	11:43283605:A:LUAD-TCGA-64-1681-Tumor-SM-2HMQE	MI		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA	NA	NA	NA	NA		NA		NA	NA	NA	NA	NA	NA	NA	NA		NA		NA						NA			NA		NA	NA	NA		NA	NA	NA			NA	NA						ENST00000511537.1:	11.37:g.43283616_43283616dupA		NA		ENST00000511537.1	37		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	HNRNPKP3-003	KNOWN	basic	processed_transcript	NA	pseudogene	OTTHUMT00000390385.1	.	KEEP	NA	-	NA	0.33	3	6	---	---	---	---	.	0	9
